Phase II study of tri-weekly administration of nanoparticle albumin-bound-paclitaxel for first-line chemotherapy in advanced and metastatic HER2- negative breast cancer
Phase 2
- Conditions
- advanced and metastatic breast cancer
- Registration Number
- JPRN-UMIN000007342
- Lead Sponsor
- Department of Breast Surgery, Kyorin University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
Past history of viral B or C hepatitis Interstitial pulmonary disease or its past history Other invasive cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method